Cargando…
Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian population
BACKGROUND: Significant progress has been made in the treatment outcomes of mantle cell lymphoma (MCL) since the introduction of cytarabine and rituximab in modern regimens. However, older patients may not readily tolerate these agents nor derive benefit. We investigated the impact of age on treatme...
Autores principales: | Yang, Xinyi, Khoo, Lay Poh, Chang, Esther Wei Yin, Yang, Valerie Shiwen, Poon, Eileen, Somasundaram, Nagavalli, Farid, Mohamad, Tang, Tiffany Pooi Ling, Tao, Miriam, Lim, Soon Thye, Chan, Jason Yongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130422/ https://www.ncbi.nlm.nih.gov/pubmed/34001056 http://dx.doi.org/10.1186/s12885-021-08326-1 |
Ejemplares similares
-
Treatment Outcomes and Survival Patterns of Asian Patients With Relapsed/Refractory Mantle Cell Lymphoma
por: Tan, Jing Yuan, et al.
Publicado: (2021) -
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era
por: Lim, Ryan Mao Heng, et al.
Publicado: (2020) -
Clinical Features of Plasmablastic Lymphoma: Case Series From an Asian Tertiary Cancer Center and Literature Review
por: Yap, Daniel Ren Yi, et al.
Publicado: (2020) -
Clinical features and survival outcomes of ocular melanoma in a multi-ethnic Asian cohort
por: Tan, Laura Ling Ying, et al.
Publicado: (2020) -
Post-Treatment Neutrophil and Lymphocyte Counts Predict Progression-Free Survival Following First-Line Chemotherapy in Hodgkin’s Lymphoma
por: Tan, Grace Fangmin, et al.
Publicado: (2023)